Phenotypic heterogeneity in multiple myeloma families.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Clinical Oncology

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2005.10.126PMID 15681516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2004

  2004cited by this paper
• Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study

  2004cited by this paper
• Multiple myeloma: evolving genetic events and host interactions

  2002cited by this paper
• Myeloma aetiology and epidemiology.

  2002cited by this paper
• Re: familial multiple myeloma: a family study and review of the literature.

  2002cited by this paper
• Re: familial multiple myeloma: a family study and review of the literature.

  2002cited by this paper
• Familial multiple myeloma: a family study and review of the literature.

  2001cited by this paper
• Germline CDKN2A mutation implicated in predisposition to multiple myeloma.

  2000cited by this paper
• Familial multiple myeloma: report of fifteen families

  1999cited by this paper
• Multiple myeloma and family history of cancer among blacks and whites in the U.S.

  1999cited by this paper
• Anticipation in familial plasma cell dyscrasias

  1998cited by this paper
• Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly.

  1998cited by this paper
• Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.

  1997cited by this paper
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• "Benign" monoclonal gammopathy--after 20 to 35 years of follow-up.

  1993cited by this paper
• Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance

  1992cited by this paper
• Multiple myeloma in three siblings.

  1985cited by this paper
• Multiple myeloma. Houses and spouses.

  1983cited by this paper
• Familial multiple myeloma. A review of thirty-seven families.

  1982cited by this paper
• Multiple myeloma: a cluster in Virginia?

  1979cited by this paper
• Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma.

  1972cited by this paper
• Multiple myeloma in spouses.

  1971cited by this paper

• Whole-Exome Sequencing-Based Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Pedigrees

  2025cites this paper
• Familial Multiple Myeloma: Insights From Epidemiology and Underlying Germline Genetic Predisposition to the Clinic.

  2025cites this paper
• Meta-analysis of effectiveness and safety of proteasome inhibitor-dependent maintenance treatment for multiple myeloma a systematic review

  2024influential citation
• FaMMily Affairs: Dissecting inherited contributions to multiple myeloma risk.

  2024cites this paper
• Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes

  2024cites this paper
• Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigrees

  2023cites this paper
• Risk of multiple myeloma and other malignancies among first‐ and second‐degree relatives of patients with multiple myeloma: A population‐based study

  2022cites this paper
• Prevalence of plasma cell and lymphoproliferative disorders among blood relatives of patients with light chain amyloidosis

  2022cites this paper
• Anticipation in multiple-case lymphoid cancer families after controlling for ascertainment biases

  2021influential citation
• Are African primary physicians suspicious enough? Challenges of multiple myeloma diagnosis in Africa

  2021cites this paper
• Targeting SIRT1 to inhibit the proliferation of multiple myeloma cells

  2021cites this paper
• Characterization of environmental and genetic factors in multiple-case lymphoid cancer families

  2020cites this paper
• Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance.

  2020cites this paper
• Monoclonal gammopathy associated neuropathy: Focusing on IgM M-protein associated neuropathy

  2020cites this paper
• Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics

  2018cites this paper
• A review of epidemiology and management of multiple myeloma in a resource poor country

  2018cites this paper
• Epidemiology of Hematologic Malignancies

  2017cites this paper
• Nonrandom occurrence of lymphoid cancer types in 140 families

  2017influential citation
• Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families

  2016cites this paper
• Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium

  2016cites this paper
• Chapter 14 – Drugs That Modulate Resistance to Antitumor Agents

  2015cites this paper
• Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features

  2015cites this paper
• Families with both Hodgkin lymphoma and multiple myeloma in their pedigrees.

  2015cites this paper
• Toll-like receptors in human multiple myeloma: new insight into inflammation-related pathogenesis.

  2014cites this paper
• Inherited genetic susceptibility to multiple myeloma

  2014cites this paper
• Detection of monoclonal IGH rearrangements in circulating cells from healthy first-degree relatives of patients with multiple myeloma

  2014cites this paper
• Inherited predisposition to multiple myeloma

  2013cites this paper
• undetermined significance in Sweden first-degree relatives of 4458 patients with monoclonal gammopathy of Risk of plasma cell and lymphoproliferative disorders among 14621

  2013cites this paper
• Waldenström Macroglobulinemia: Clinical and Immunological Aspects, Natural History, Cell of Origin, and Emerging Mouse Models

  2013cites this paper
• Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.

  2012cites this paper
• Vachon characteristics multiple myeloma : epidemiology , risk factors , and biological Familial monoclonal gammopathy of undetermined significance and

  2012cites this paper
• Multipl miyelomlu türk hastalarda EORTC QLQ kullanılarak hayat kalitesi değerlendirilmesi

  2011cites this paper
• Inpatient Rehabilitation in Persons With Multiple Myeloma‐Associated Fractures: An Analysis of 8 Consecutive Inpatient Admissions

  2011cites this paper
• Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM.

  2011cites this paper
• Identification of predictive molecular markers for disease progression and response to therapy in monoclonal gammopathies

  2011cites this paper
• Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).

  2011cites this paper
• Familial plasma cell disorders and associated cancers.

  2011cites this paper
• Neurological manifestaions among Sudanese patients with multiple myeloma

  2011cites this paper
• Heritability of hematologic malignancies: from pedigrees to genomics.

  2010influential citation
• 63 – Plasma Cell Tumors: Multiple Myeloma And Solitary Plasmacytoma

  2010cites this paper
• Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis

  2009cites this paper
• Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.

  2009cites this paper
• Initial Report of a Family Registry of Multiple Myeloma

  2009cites this paper
• Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.

  2009cites this paper
• Population-based studies on familiality and prognosis in patients with monoclonal gammopathies

  2009cites this paper
• Familial myeloma and monoclonal gammopathy: A report of eight African American families

  2009influential citation
• MGUS, multiple myeloma, and paratarg-7.

  2009cites this paper
• Familial multiple myeloma

  2009cites this paper
• Familial multiple myeloma.

  2009cites this paper
• Angiotensin II blockade in Marfan's syndrome.

  2008cites this paper
• Familial myeloma.

  2008cites this paper
• A Phase I Trial of Irinotecan Alternating With Epirubicin in Patients With Advanced Malignancies

  2008cites this paper
• Genetic counseling for DAPK1 mutation in a chronic lymphocytic leukemia family.

  2008cites this paper
• Epidemiology of Multiple Myeloma

  2008cites this paper
• Familial myeloma.

  2008cites this paper
• Drugs That Modulate Resistance to Antitumor Agents

  2008cites this paper
• Individualizing therapy using molecular markers in multiple myeloma.

  2007cites this paper
• Excess of early onset multiple myeloma in endometrial cancer probands and their relatives suggests common susceptibility.

  2007cites this paper
• Familial Multiple Myeloma: Report on Two Families and Discussion of Screening Options

  2007influential citation
• Genetic events in the pathogenesis of multiple myeloma.

  2007influential citation
• Epidemiology of the plasma-cell disorders.

  2007cites this paper
• Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the future

  2006cites this paper
• Plasma cell dyscrasias and leukemias.

  2006cites this paper
• Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: A population‐based case‐control study

  2006cites this paper
• Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.

  2006cites this paper
• Familial risks and temporal incidence trends of multiple myeloma.

  2006cites this paper
• Early genetic events provide the basis for a clinical classification of multiple myeloma.

  2005influential citation
• Report on the Relative Efficacy of Oral Cancer Therapy for Medicare Beneficiaries Versus Currently Covered Therapy: Part 4 Thalidomide for Multiple Myeloma

  2005influential citation
• An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer

  2005cites this paper
• Molecular pathogenesis and a consequent classification of multiple myeloma.

  2005cites this paper
• Epidermal growth factor inhibition in solid tumours

  2005cites this paper